Follow us for updates
© 2021
Read the Story →

Pfizer Vaccine to Secure Emergency Use Clearance in Philippines

A first in the country.
by Ara Eugenio
Jan 6, 2021
Photo/s: shutterstock

The COVID-19 vaccine from Pfizer and BioNTech could secure emergency use authorization in the Philippines as early as this week, offering hope for a faster immunization rollout, the head of the Food and Drug Administration said Wednesday.

The vaccine from U.S.-based Pfizer will be the first to get EUA from the Philippines. It applied for the certification last Dec. 23, FDA Director General Eric Domingo told ANC.

“Believe me, we are making this as quick as possible and I'm quite sure we'll be out with the authorization within a week. That’s quite short compared to other countries," he said. 


Got COVID Vaccine Questions? Here are Expert Answers 

How Much Will COVID-19 Vaccines Cost? 

The country's top businessmen earlier placed an advance order for 2.6 million vaccines from the UK's AstraZeneca, co-developed with Oxford University.

China's Sinovac and Russia's Gamaleya have asked for requirements to secure emergency use authorization, Domingo said.

Continue reading below ↓

President Rodrigo Duterte's security earlier received vaccines from China's Sinopharm.


What is the Philippines COVID Vaccine Plan?

Who Gets COVID-19 Vaccine in Philippines First?

What If You Don't Want a COVID Vaccine?

Continue reading below ↓
Recommended Videos
Latest Headlines
Read Next
Recent News
President Duterte reportedly eyeing VP spot.
To the Japanese, they symbolize perseverance and good luck.
Partido Federal 'adopts' Duterte-Carpio of Lakas CMD.
She's moving to national politics.
It can be a confluence of factors, Usec. Vergeire says.
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to newsletter, you agree to our Terms of Service and Privacy Policy.